APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Parathyroid Hormone Analog

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Parathyroid Hormone Analog Industry Growth and Trends Forecast to 2032

Report ID 174022300120 December 2025104 pages

Choose your research edition.

Industry ResearchParathyroid Hormone Analog Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Parathyroid Hormone Analog Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Parathyroid Hormone Analog Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parathyroid Hormone Analog Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Parathyroid Hormone Analog Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Parathyroid Hormone Analog market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Parathyroid Hormone Analog is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Parathyroid Hormone Analog is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parathyroid Hormone Analog is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Parathyroid Hormone Analog include Abbott Laboratories, ALZA Corporation, Cell Genesys Inc, Natpara, OSI Pharmaceuticals, Paladin Labs Inc, GlaxoSmithKline Plc, Pfizer and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Parathyroid Hormone Analog market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Parathyroid Hormone Analog market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parathyroid Hormone Analog market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parathyroid Hormone Analog.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Parathyroid Hormone Analog market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Parathyroid Hormone Analog Market by Company

Abbott Laboratories

ALZA Corporation

Cell Genesys Inc

Natpara

OSI Pharmaceuticals

Paladin Labs Inc

GlaxoSmithKline Plc

Pfizer

Eli Lilly

Merck

Sanofi SA

Parathyroid Hormone Analog Segment by Type

Abaloparatide

Human Parathyroid Hormone Recombinant

Teriparatide

Parathyroid Hormone Analog Segment by Application

Hospitals

Clinics

Other

Parathyroid Hormone Analog Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parathyroid Hormone Analog market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parathyroid Hormone Analog and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parathyroid Hormone Analog.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Parathyroid Hormone Analog manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Parathyroid Hormone Analog in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Abaloparatide Table 2. Major Company of Human Parathyroid Hormone Recombinant Table 3. Major Company of Teriparatide Table 4. Global Parathyroid Hormone Analog Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 6. Global Parathyroid Hormone Analog Sales Market Share in Volume by Type (2021-2026) Table 7. Global Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 8. Global Parathyroid Hormone Analog Sales Market Share in Value by Type (2021-2026) Table 9. Global Parathyroid Hormone Analog Price by Type (2021-2026) & (US$/Unit) Table 10. Global Parathyroid Hormone Analog Sales by Type (2027-2032) & (K Units) Table 11. Global Parathyroid Hormone Analog Sales Market Share in Volume by Type (2027-2032) Table 12. Global Parathyroid Hormone Analog Sales by Type (2027-2032) & (US$ Million) Table 13. Global Parathyroid Hormone Analog Sales Market Share in Value by Type (2027-2032) Table 14. Global Parathyroid Hormone Analog Price by Type (2027-2032) & (US$/Unit) Table 15. North America Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 16. North America Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 18. Europe Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 22. Latin America Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Parathyroid Hormone Analog Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Parathyroid Hormone Analog Sales by Type (2021-2026) & (US$ Million) Table 25. Parathyroid Hormone Analog Industry Trends Table 26. Parathyroid Hormone Analog Industry Drivers Table 27. Parathyroid Hormone Analog Industry Opportunities and Challenges Table 28. Parathyroid Hormone Analog Industry Restraints Table 29. Global Parathyroid Hormone Analog Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Parathyroid Hormone Analog Revenue Market Share by Company (2021-2026) Table 31. Global Parathyroid Hormone Analog Sales by Company (2021-2026) & (K Units) Table 32. Global Parathyroid Hormone Analog Sales Share by Company (2021-2026) Table 33. Global Parathyroid Hormone Analog Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Parathyroid Hormone Analog Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Parathyroid Hormone Analog Major Company Production Sites and Headquarters Table 36. Global Parathyroid Hormone Analog Company, Product Type & Application Table 37. Global Parathyroid Hormone Analog Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Parathyroid Hormone Analog by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Parathyroid Hormone Analog Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Parathyroid Hormone Analog Sales by Region (2021-2026) & (K Units) Table 42. Global Parathyroid Hormone Analog Sales Market Share in Volume by Region (2021-2026) Table 43. Global Parathyroid Hormone Analog Sales by Region (2021-2026) & (US$ Million) Table 44. Global Parathyroid Hormone Analog Sales Market Share in Value by Region (2021-2026) Table 45. Global Parathyroid Hormone Analog Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Parathyroid Hormone Analog Sales by Region (2027-2032) & (K Units) Table 47. Global Parathyroid Hormone Analog Sales Market Share in Volume by Region (2027-2032) Table 48. Global Parathyroid Hormone Analog Sales by Region (2027-2032) & (US$ Million) Table 49. Global Parathyroid Hormone Analog Sales Market Share in Value by Region (2027-2032) Table 50. Global Parathyroid Hormone Analog Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Parathyroid Hormone Analog Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 53. Global Parathyroid Hormone Analog Sales Market Share in Volume by Application (2021-2026) Table 54. Global Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 55. Global Parathyroid Hormone Analog Sales Market Share in Value by Application (2021-2026) Table 56. Global Parathyroid Hormone Analog Price by Application (2021-2026) & (US$/Unit) Table 57. Global Parathyroid Hormone Analog Sales by Application (2027-2032) & (K Units) Table 58. Global Parathyroid Hormone Analog Sales Market Share in Volume by Application (2027-2032) Table 59. Global Parathyroid Hormone Analog Sales by Application (2027-2032) & (US$ Million) Table 60. Global Parathyroid Hormone Analog Sales Market Share in Value by Application (2027-2032) Table 61. Global Parathyroid Hormone Analog Price by Application (2027-2032) & (US$/Unit) Table 62. North America Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 63. North America Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 65. Europe Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 69. Latin America Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Parathyroid Hormone Analog Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Parathyroid Hormone Analog Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Laboratories Company Information Table 73. Abbott Laboratories Business Overview Table 74. Abbott Laboratories Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Abbott Laboratories Parathyroid Hormone Analog Product Portfolio Table 76. Abbott Laboratories Recent Development Table 77. ALZA Corporation Company Information Table 78. ALZA Corporation Business Overview Table 79. ALZA Corporation Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ALZA Corporation Parathyroid Hormone Analog Product Portfolio Table 81. ALZA Corporation Recent Development Table 82. Cell Genesys Inc Company Information Table 83. Cell Genesys Inc Business Overview Table 84. Cell Genesys Inc Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Cell Genesys Inc Parathyroid Hormone Analog Product Portfolio Table 86. Cell Genesys Inc Recent Development Table 87. Natpara Company Information Table 88. Natpara Business Overview Table 89. Natpara Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Natpara Parathyroid Hormone Analog Product Portfolio Table 91. Natpara Recent Development Table 92. OSI Pharmaceuticals Company Information Table 93. OSI Pharmaceuticals Business Overview Table 94. OSI Pharmaceuticals Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. OSI Pharmaceuticals Parathyroid Hormone Analog Product Portfolio Table 96. OSI Pharmaceuticals Recent Development Table 97. Paladin Labs Inc Company Information Table 98. Paladin Labs Inc Business Overview Table 99. Paladin Labs Inc Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Paladin Labs Inc Parathyroid Hormone Analog Product Portfolio Table 101. Paladin Labs Inc Recent Development Table 102. GlaxoSmithKline Plc Company Information Table 103. GlaxoSmithKline Plc Business Overview Table 104. GlaxoSmithKline Plc Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Plc Parathyroid Hormone Analog Product Portfolio Table 106. GlaxoSmithKline Plc Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Parathyroid Hormone Analog Product Portfolio Table 111. Pfizer Recent Development Table 112. Eli Lilly Company Information Table 113. Eli Lilly Business Overview Table 114. Eli Lilly Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Eli Lilly Parathyroid Hormone Analog Product Portfolio Table 116. Eli Lilly Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Parathyroid Hormone Analog Product Portfolio Table 121. Merck Recent Development Table 122. Sanofi SA Company Information Table 123. Sanofi SA Business Overview Table 124. Sanofi SA Parathyroid Hormone Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi SA Parathyroid Hormone Analog Product Portfolio Table 126. Sanofi SA Recent Development Table 127. North America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Parathyroid Hormone Analog Sales by Country (2021-2026) & (K Units) Table 129. North America Parathyroid Hormone Analog Sales Market Share by Country (2021-2026) Table 130. North America Parathyroid Hormone Analog Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Parathyroid Hormone Analog Sales Market Share Forecast by Country (2027-2032) Table 132. North America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Parathyroid Hormone Analog Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Parathyroid Hormone Analog Market Share by Country (2021-2026) Table 135. North America Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Parathyroid Hormone Analog Market Share Forecast by Country (2027-2032) Table 137. Europe Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Parathyroid Hormone Analog Sales by Country (2021-2026) & (K Units) Table 139. Europe Parathyroid Hormone Analog Sales Market Share by Country (2021-2026) Table 140. Europe Parathyroid Hormone Analog Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Parathyroid Hormone Analog Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Parathyroid Hormone Analog Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Parathyroid Hormone Analog Market Share by Country (2021-2026) Table 145. Europe Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Parathyroid Hormone Analog Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Parathyroid Hormone Analog Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Parathyroid Hormone Analog Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Parathyroid Hormone Analog Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Parathyroid Hormone Analog Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Parathyroid Hormone Analog Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Parathyroid Hormone Analog Market Share by Country (2021-2026) Table 155. Asia-Pacific Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Parathyroid Hormone Analog Market Share Forecast by Country (2027-2032) Table 157. Latin America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Parathyroid Hormone Analog Sales by Country (2021-2026) & (K Units) Table 159. Latin America Parathyroid Hormone Analog Sales Market Share by Country (2021-2026) Table 160. Latin America Parathyroid Hormone Analog Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Parathyroid Hormone Analog Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Parathyroid Hormone Analog Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Parathyroid Hormone Analog Market Share by Country (2021-2026) Table 165. Latin America Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Parathyroid Hormone Analog Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Parathyroid Hormone Analog Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Parathyroid Hormone Analog Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Parathyroid Hormone Analog Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Parathyroid Hormone Analog Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Parathyroid Hormone Analog Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Parathyroid Hormone Analog Market Share by Country (2021-2026) Table 175. Middle East and Africa Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Parathyroid Hormone Analog Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Parathyroid Hormone Analog Distributors List Table 180. Parathyroid Hormone Analog Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Parathyroid Hormone Analog Image Figure 2. Global Parathyroid Hormone Analog Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parathyroid Hormone Analog Market Size (2021-2032) & (US$ Million) Figure 4. Global Parathyroid Hormone Analog Sales (2021-2032) & (K Units) Figure 5. Abaloparatide Image Figure 6. Global Abaloparatide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Human Parathyroid Hormone Recombinant Image Figure 8. Global Human Parathyroid Hormone Recombinant Sales YoY Growth (2021-2032) & (K Units) Figure 9. Teriparatide Image Figure 10. Global Teriparatide Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Parathyroid Hormone Analog Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Parathyroid Hormone Analog Market Share by Type 2025 VS 2032 Figure 13. North America Parathyroid Hormone Analog Sales Market Share in Volume by Type in 2025 Figure 14. North America Parathyroid Hormone Analog Sales Market Share in Value by Type in 2025 Figure 15. Europe Parathyroid Hormone Analog Sales Market Share in Volume by Type in 2025 Figure 16. Europe Parathyroid Hormone Analog Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Parathyroid Hormone Analog Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Parathyroid Hormone Analog Sales Market Share in Value by Type in 2025 Figure 19. Latin America Parathyroid Hormone Analog Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Parathyroid Hormone Analog Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Parathyroid Hormone Analog Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Parathyroid Hormone Analog Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Parathyroid Hormone Analog Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Parathyroid Hormone Analog Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Parathyroid Hormone Analog Market Share by Application 2025 VS 2032 Figure 33. North America Parathyroid Hormone Analog Sales Market Share in Volume by Application in 2025 Figure 34. North America Parathyroid Hormone Analog Sales Market Share in Value by Application in 2025 Figure 35. Europe Parathyroid Hormone Analog Sales Market Share in Volume by Application in 2025 Figure 36. Europe Parathyroid Hormone Analog Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Parathyroid Hormone Analog Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Parathyroid Hormone Analog Sales Market Share in Value by Application in 2025 Figure 39. Latin America Parathyroid Hormone Analog Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Parathyroid Hormone Analog Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Parathyroid Hormone Analog Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Parathyroid Hormone Analog Sales Market Share in Value by Application in 2025 Figure 43. North America Parathyroid Hormone Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Parathyroid Hormone Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Parathyroid Hormone Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Parathyroid Hormone Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Parathyroid Hormone Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Parathyroid Hormone Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Parathyroid Hormone Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Parathyroid Hormone Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Parathyroid Hormone Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Parathyroid Hormone Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Parathyroid Hormone Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Parathyroid Hormone Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Parathyroid Hormone Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Parathyroid Hormone Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Parathyroid Hormone Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Parathyroid Hormone Analog Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Parathyroid Hormone Analog Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Abaloparatide
  • Human Parathyroid Hormone Recombinant
  • Teriparatide
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Abbott Laboratories
  • ALZA Corporation
  • Cell Genesys Inc
  • Natpara
  • OSI Pharmaceuticals
  • Paladin Labs Inc
  • GlaxoSmithKline Plc
  • Pfizer
  • Eli Lilly
  • Merck
  • Sanofi SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Parathyroid Hormone Analog Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Parathyroid Hormone Analog Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Parathyroid Hormone Analog Market by Type
  6. 1.3.1 Abaloparatide
  7. 1.3.2 Human Parathyroid Hormone Recombinant
  8. 1.3.3 Teriparatide
  9. 1.4 Global Parathyroid Hormone Analog Market Size by Type
  10. 1.4.1 Global Parathyroid Hormone Analog Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Parathyroid Hormone Analog Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Parathyroid Hormone Analog Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Parathyroid Hormone Analog Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Parathyroid Hormone Analog Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Parathyroid Hormone Analog Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Parathyroid Hormone Analog Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Parathyroid Hormone Analog Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Parathyroid Hormone Analog Industry Trends
  2. 2.2 Parathyroid Hormone Analog Industry Drivers
  3. 2.3 Parathyroid Hormone Analog Industry Opportunities and Challenges
  4. 2.4 Parathyroid Hormone Analog Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Parathyroid Hormone Analog Revenue (2021-2026)
  2. 3.2 Global Top Players by Parathyroid Hormone Analog Sales (2021-2026)
  3. 3.3 Global Top Players by Parathyroid Hormone Analog Price (2021-2026)
  4. 3.4 Global Parathyroid Hormone Analog Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Parathyroid Hormone Analog Major Company Production Sites & Headquarters
  6. 3.6 Global Parathyroid Hormone Analog Company, Product Type & Application
  7. 3.7 Global Parathyroid Hormone Analog Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Parathyroid Hormone Analog Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Parathyroid Hormone Analog Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Parathyroid Hormone Analog Tier 1, Tier 2, and Tier 3
4 Parathyroid Hormone Analog Regional Status and Outlook
  1. 4.1 Global Parathyroid Hormone Analog Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Parathyroid Hormone Analog Historic Market Size by Region
  3. 4.2.1 Global Parathyroid Hormone Analog Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Parathyroid Hormone Analog Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Parathyroid Hormone Analog Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Parathyroid Hormone Analog Forecasted Market Size by Region
  7. 4.3.1 Global Parathyroid Hormone Analog Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Parathyroid Hormone Analog Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Parathyroid Hormone Analog Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Parathyroid Hormone Analog by Application
  1. 5.1 Parathyroid Hormone Analog Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Parathyroid Hormone Analog Market Size by Application
  6. 5.2.1 Global Parathyroid Hormone Analog Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Parathyroid Hormone Analog Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Parathyroid Hormone Analog Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Parathyroid Hormone Analog Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Parathyroid Hormone Analog Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Parathyroid Hormone Analog Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Parathyroid Hormone Analog Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Parathyroid Hormone Analog Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Parathyroid Hormone Analog Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 ALZA Corporation
  8. 6.2.1 ALZA Corporation Company Information
  9. 6.2.2 ALZA Corporation Business Overview
  10. 6.2.3 ALZA Corporation Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ALZA Corporation Parathyroid Hormone Analog Product Portfolio
  12. 6.2.5 ALZA Corporation Recent Developments
  13. 6.3 Cell Genesys Inc
  14. 6.3.1 Cell Genesys Inc Company Information
  15. 6.3.2 Cell Genesys Inc Business Overview
  16. 6.3.3 Cell Genesys Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cell Genesys Inc Parathyroid Hormone Analog Product Portfolio
  18. 6.3.5 Cell Genesys Inc Recent Developments
  19. 6.4 Natpara
  20. 6.4.1 Natpara Company Information
  21. 6.4.2 Natpara Business Overview
  22. 6.4.3 Natpara Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Natpara Parathyroid Hormone Analog Product Portfolio
  24. 6.4.5 Natpara Recent Developments
  25. 6.5 OSI Pharmaceuticals
  26. 6.5.1 OSI Pharmaceuticals Company Information
  27. 6.5.2 OSI Pharmaceuticals Business Overview
  28. 6.5.3 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 OSI Pharmaceuticals Parathyroid Hormone Analog Product Portfolio
  30. 6.5.5 OSI Pharmaceuticals Recent Developments
  31. 6.6 Paladin Labs Inc
  32. 6.6.1 Paladin Labs Inc Company Information
  33. 6.6.2 Paladin Labs Inc Business Overview
  34. 6.6.3 Paladin Labs Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Paladin Labs Inc Parathyroid Hormone Analog Product Portfolio
  36. 6.6.5 Paladin Labs Inc Recent Developments
  37. 6.7 GlaxoSmithKline Plc
  38. 6.7.1 GlaxoSmithKline Plc Company Information
  39. 6.7.2 GlaxoSmithKline Plc Business Overview
  40. 6.7.3 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Plc Parathyroid Hormone Analog Product Portfolio
  42. 6.7.5 GlaxoSmithKline Plc Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Parathyroid Hormone Analog Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly Parathyroid Hormone Analog Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck Parathyroid Hormone Analog Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Sanofi SA
  62. 6.11.1 Sanofi SA Company Information
  63. 6.11.2 Sanofi SA Business Overview
  64. 6.11.3 Sanofi SA Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi SA Parathyroid Hormone Analog Product Portfolio
  66. 6.11.5 Sanofi SA Recent Developments
7 North America by Country
  1. 7.1 North America Parathyroid Hormone Analog Sales by Country
  2. 7.1.1 North America Parathyroid Hormone Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Parathyroid Hormone Analog Sales by Country (2021-2026)
  4. 7.1.3 North America Parathyroid Hormone Analog Sales Forecast by Country (2027-2032)
  5. 7.2 North America Parathyroid Hormone Analog Market Size by Country
  6. 7.2.1 North America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Parathyroid Hormone Analog Market Size by Country (2021-2026)
  8. 7.2.3 North America Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Parathyroid Hormone Analog Sales by Country
  2. 8.1.1 Europe Parathyroid Hormone Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Parathyroid Hormone Analog Sales by Country (2021-2026)
  4. 8.1.3 Europe Parathyroid Hormone Analog Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Parathyroid Hormone Analog Market Size by Country
  6. 8.2.1 Europe Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Parathyroid Hormone Analog Market Size by Country (2021-2026)
  8. 8.2.3 Europe Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Parathyroid Hormone Analog Sales by Country
  2. 9.1.1 Asia-Pacific Parathyroid Hormone Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Parathyroid Hormone Analog Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Parathyroid Hormone Analog Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Parathyroid Hormone Analog Market Size by Country
  6. 9.2.1 Asia-Pacific Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Parathyroid Hormone Analog Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Parathyroid Hormone Analog Sales by Country
  2. 10.1.1 South America Parathyroid Hormone Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Parathyroid Hormone Analog Sales by Country (2021-2026)
  4. 10.1.3 South America Parathyroid Hormone Analog Sales Forecast by Country (2027-2032)
  5. 10.2 South America Parathyroid Hormone Analog Market Size by Country
  6. 10.2.1 South America Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Parathyroid Hormone Analog Market Size by Country (2021-2026)
  8. 10.2.3 South America Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Parathyroid Hormone Analog Sales by Country
  2. 11.1.1 Middle East and Africa Parathyroid Hormone Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Parathyroid Hormone Analog Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Parathyroid Hormone Analog Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Parathyroid Hormone Analog Market Size by Country
  6. 11.2.1 Middle East and Africa Parathyroid Hormone Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Parathyroid Hormone Analog Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Parathyroid Hormone Analog Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Parathyroid Hormone Analog Value Chain Analysis
  2. 12.1.1 Parathyroid Hormone Analog Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Parathyroid Hormone Analog Production Mode & Process
  7. 12.2 Parathyroid Hormone Analog Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Parathyroid Hormone Analog Distributors
  10. 12.2.3 Parathyroid Hormone Analog Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst